| Reference |
|---|
Essex A, Pineda J, Acharya G, Xin H, Evans J, Iorns E, et al. Replication Study: Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. elife. 2019;8: pubmed publisher
|
Kumar D, New J, Vishwakarma V, Joshi R, Enders J, Lin F, et al. Cancer-Associated Fibroblasts Drive Glycolysis in a Targetable Signaling Loop Implicated in Head and Neck Squamous Cell Carcinoma Progression. Cancer Res. 2018;78:3769-3782 pubmed publisher
|
Ferrucci A, Moschetta M, Frassanito M, Berardi S, Catacchio I, Ria R, et al. A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target. Clin Cancer Res. 2014;20:5796-807 pubmed publisher
|
Timby N, Lonnerdal B, Hernell O, Domellöf M. Cardiovascular risk markers until 12 mo of age in infants fed a formula supplemented with bovine milk fat globule membranes. Pediatr Res. 2014;76:394-400 pubmed publisher
|
Hudson J, Ha J, Sabourin V, Ahn R, La Selva R, Livingstone J, et al. p66ShcA promotes breast cancer plasticity by inducing an epithelial-to-mesenchymal transition. Mol Cell Biol. 2014;34:3689-701 pubmed publisher
|
Chen J, Xiong Y, Dong K, Luo J, Yue L, Chen Q. Clinical significance of joint detection of serum VEGF, SIL-2R and HGF in patients with primary hepatocellular carcinoma before and after percutaneous microwave coagulation therapy. Asian Pac J Cancer Prev. 2014;15:4545-8 pubmed
|
Vasuri F, Fittipaldi S, Abualhin M, DeGiovanni A, Gargiulo M, Stella A, et al. Biochemical and immunomorphological evaluation of hepatocyte growth factor and c-Met pathway in patients with critical limb ischemia. Eur J Vasc Endovasc Surg. 2014;48:430-7 pubmed publisher
|
Lee Y, Park H, Woo S, Park E, Kang J. RhoA/phosphatidylinositol 3-kinase/protein kinase B/mitogen-activated protein kinase signaling after growth arrest-specific protein 6/mer receptor tyrosine kinase engagement promotes epithelial cell growth and wound repair via upregulation of hepatoc. J Pharmacol Exp Ther. 2014;350:563-77 pubmed publisher
|
Conforti A, Scarsella M, Starc N, Giorda E, Biagini S, Proia A, et al. Microvescicles derived from mesenchymal stromal cells are not as effective as their cellular counterpart in the ability to modulate immune responses in vitro. Stem Cells Dev. 2014;23:2591-9 pubmed publisher
|
Wen Q, Zhou C, Luo W, Zhou M, Ma L. Pro-osteogenic effects of fibrin glue in treatment of avascular necrosis of the femoral head in vivo by hepatocyte growth factor-transgenic mesenchymal stem cells. J Transl Med. 2014;12:114 pubmed publisher
|
Patel M, Pothula S, Xu Z, Lee A, Goldstein D, Pirola R, et al. The role of the hepatocyte growth factor/c-MET pathway in pancreatic stellate cell-endothelial cell interactions: antiangiogenic implications in pancreatic cancer. Carcinogenesis. 2014;35:1891-900 pubmed publisher
|
Chen P, Liu K, Hsu P, Wei C, Bai C, Ho L, et al. Induction of immunomodulatory monocytes by human mesenchymal stem cell-derived hepatocyte growth factor through ERK1/2. J Leukoc Biol. 2014;96:295-303 pubmed publisher
|
Tabernero J, Elez M, Herranz M, Rico I, Prudkin L, Andreu J, et al. A pharmacodynamic/pharmacokinetic study of ficlatuzumab in patients with advanced solid tumors and liver metastases. Clin Cancer Res. 2014;20:2793-804 pubmed publisher
|
Tinazzi E, Barbieri A, Rigo A, Patuzzo G, Beri R, Gerli R, et al. In rheumatoid arthritis soluble CD30 ligand is present at high levels and induces apoptosis of CD30(+)T cells. Immunol Lett. 2014;161:236-40 pubmed publisher
|